Effectiveness and safety of transarterial chemoembolization combined with PD-1 inhibitors and lenvatinib for unresectable intrahepatic cholangiocarcinoma

Abstract Background The objective of this study was to evaluate the therapeutic effectiveness and safety of transarterial chemoembolization (TACE) combined with programmed cell death-1 (PD-1) inhibitors and lenvatinib in the treatment of unresectable intrahepatic cholangiocarcinoma (uICC). Methods T...

Full description

Bibliographic Details
Published in:European Radiology Experimental
Main Authors: Jin-Tao Huang, Di Hu, Xin Hong, Wen-Jie Zhou, Jian Shen, Peng-Hua Lv, Xiao-Li Zhu
Format: Article
Language:English
Published: SpringerOpen 2025-02-01
Subjects:
Camrelizumab
Chemoembolization (therapeutic)
Cholangiocarcinoma
Lenvatinib
Tislelizumab
Online Access:https://doi.org/10.1186/s41747-025-00563-4

Internet

https://doi.org/10.1186/s41747-025-00563-4

Similar Items